Pharmadrug released its earnings results on Aug 22, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.

Q: Is Pharmadrug overvalued?

According to Wall Street analysts Pharmadrug’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Pharmadrug pay dividends?

Pharmadrug does not currently pay dividends.

Q: What is Pharmadrug’s EPS estimate?

Pharmadrug’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Pharmadrug have?

Pharmadrug has 108,234,380 shares outstanding.

Q: What happened to Pharmadrug’s price movement after its last earnings report?

Pharmadrug reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Pharmadrug?

Currently, no hedge funds are holding shares in TSE:PHRX

Compare

33 Followers

PHRX Stock Chart & Stats

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.03

Previous CloseN/A

Volume5.00K

Average Volume (3M)81.06K

Market Cap

C$1.62M

Enterprise ValueC$2.62M

Total Cash (Recent Filing)C$74.77K

Total Debt (Recent Filing)C$1.38M

Price to Earnings (P/E)―

Beta1.84

Next Earnings

May 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding108,234,380

10 Day Avg. Volume95,720

30 Day Avg. Volume81,056

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Pharmadrug News

PharmaDrug Corrects Share Issuance in Canurta Acquisition Deal

Pharmadrug ( ($TSE:PHRX) ) has shared an update. PharmaDrug Inc. has corrected a previous announcement regarding its acquisition...

1M ago

PharmaDrug to Acquire 40% Stake in Biotech Firm Canurta

Pharmadrug ( ($TSE:PHRX) ) has shared an update. PharmaDrug Inc. has signed a non-binding Letter of Intent to...

1M ago

PharmaDrug Announces CEO Resignation and Leadership Transition

Pharmadrug ( ($TSE:PHRX) ) just unveiled an announcement. PharmaDrug Inc. announced the resignation of Rob Steen as CEO...

3M ago

PharmaDrug Initiates Strategic Review to Enhance Shareholder Value

Pharmadrug ( ($TSE:PHRX) ) just unveiled an update. PharmaDrug Inc. has initiated a strategic review process led by...

3M ago

PharmaDrug Completes Strategic Debenture Issuance

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug Inc. has successfully issued over $412,000 in debentures to replace its...

10M ago

PharmaDrug Debenture Units Issuance Announcement

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug Inc. is issuing $414,523 in debenture units to replace outstanding convertible...

10M ago

PharmaDrug Advances PD-001 for Clinical Trials

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug’s Sairiyo Therapeutics has successfully completed a stability study of its reformulated...

10M ago

PharmaDrug Begins Clinical Trial for Infectious Disease Treatment

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug has commenced a clinical study for PD-001, a patented enteric-coated cepharanthine,...

12M ago

PharmaDrug Advances PD-001 in Fight Against Viral Diseases

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug Inc., through its subsidiary Sairiyo Therapeutics, is advancing the clinical development...

1y ago

PharmaDrug’s Cepharanthine Shows Potential Against Monkeypox

Pharmadrug (TSE:PHRX) has released an update. PharmaDrug’s subsidiary Sairiyo Therapeutics has reported that cepharanthine, a component of their...

1y ago

PHRX FAQ

What was Pharmadrug’s price range in the past 12 months?

Pharmadrug lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.

What is Pharmadrug’s market cap?

Pharmadrug’s market cap is C$1.62M.

When is Pharmadrug’s upcoming earnings report date?

Pharmadrug’s upcoming earnings report date is May 06, 2026 which is in 239 days.

How were Pharmadrug’s earnings last quarter?

Pharmadrug released its earnings results on Aug 22, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.

Is Pharmadrug overvalued?

According to Wall Street analysts Pharmadrug’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pharmadrug pay dividends?

Pharmadrug does not currently pay dividends.

What is Pharmadrug’s EPS estimate?

Pharmadrug’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pharmadrug have?

Pharmadrug has 108,234,380 shares outstanding.

What happened to Pharmadrug’s price movement after its last earnings report?

Pharmadrug reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Pharmadrug?

Currently, no hedge funds are holding shares in TSE:PHRX

Company Description

Pharmadrug

Pharmadrug (PHRX) is a publicly traded pharmaceutical company focused on the research, development, and commercialization of controlled substances and natural medicines. The company operates in the healthcare and biotechnology sectors, with a core emphasis on developing novel therapies and treatments that leverage both synthetic and plant-derived compounds. Pharmadrug aims to address unmet medical needs in various therapeutic areas, including mental health and pain management.